Cargando…
Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient
Vaccine-induced thrombotic thrombocytopenia (VITT) is triggered by vaccination against COVID-19 with adenovirus vector vaccines (ChAdOx1 nCoV-19; Ad26.COV2-S). In this observational study, we followed VITT patients for changes in their reactivity of platelet-activating antiplatelet factor 4 (PF4) im...
Autores principales: | Schönborn, Linda, Thiele, Thomas, Kaderali, Lars, Günther, Albrecht, Hoffmann, Till, Seck, Sabrina Edigna, Selleng, Kathleen, Greinacher, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8816791/ https://www.ncbi.nlm.nih.gov/pubmed/35113987 http://dx.doi.org/10.1182/blood.2021014214 |
Ejemplares similares
-
ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia
por: Karnes, Jason H., et al.
Publicado: (2022) -
Natural history of PF4 antibodies in vaccine-induced immune thrombocytopenia and thrombosis
por: Craven, Brian, et al.
Publicado: (2022) -
The clinical and laboratory diagnosis of vaccine-induced immune thrombotic thrombocytopenia
por: Bissola, Anna-Lise, et al.
Publicado: (2022) -
A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination
por: Handtke, Stefan, et al.
Publicado: (2021) -
A novel flow cytometry procoagulant assay for diagnosis of vaccine-induced immune thrombotic thrombocytopenia
por: Lee, Christine S.M., et al.
Publicado: (2022)